D'APRILE, GIANVITO
 Distribuzione geografica
Continente #
NA - Nord America 2.173
AS - Asia 666
EU - Europa 483
SA - Sud America 153
Continente sconosciuto - Info sul continente non disponibili 43
AF - Africa 27
Totale 3.545
Nazione #
US - Stati Uniti d'America 2.136
SG - Singapore 292
CN - Cina 145
IT - Italia 142
BR - Brasile 116
SE - Svezia 98
HK - Hong Kong 76
RU - Federazione Russa 65
FR - Francia 55
VN - Vietnam 39
GB - Regno Unito 35
DE - Germania 31
IN - India 23
BE - Belgio 21
BD - Bangladesh 20
CA - Canada 17
IQ - Iraq 15
CO - Colombia 13
AR - Argentina 12
TR - Turchia 10
MX - Messico 8
MY - Malesia 6
ZA - Sudafrica 6
AT - Austria 5
ES - Italia 5
NL - Olanda 5
PK - Pakistan 5
VE - Venezuela 5
CR - Costa Rica 4
JP - Giappone 4
ET - Etiopia 3
FI - Finlandia 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
PL - Polonia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
EC - Ecuador 2
ID - Indonesia 2
JO - Giordania 2
KG - Kirghizistan 2
NG - Nigeria 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UA - Ucraina 2
AL - Albania 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SO - Somalia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.503
Città #
Ashburn 298
Fairfield 254
Chandler 252
Singapore 177
San Jose 130
Woodbridge 129
Seattle 113
Houston 101
Cambridge 100
Wilmington 86
Nyköping 80
Beijing 76
Hong Kong 76
Milan 52
Ann Arbor 48
Council Bluffs 38
Lawrence 25
Los Angeles 25
Roxbury 25
Lauterbourg 22
Brussels 21
Dallas 21
Ruvo Di Puglia 20
Columbus 18
Rome 17
The Dalles 17
Brooklyn 16
Dearborn 16
Des Moines 16
Ho Chi Minh City 16
Inglewood 14
Frankfurt am Main 12
Bari 11
Hanoi 11
São Paulo 11
Munich 10
New York 10
Paris 10
Chicago 9
Baghdad 7
Edinburgh 7
Boardman 6
London 6
Montreal 6
Pune 6
Turin 6
Hefei 5
Orem 5
Phoenix 5
San Francisco 5
Santa Clara 5
Amsterdam 4
Atlanta 4
Belo Horizonte 4
Karbala 4
Monmouth Junction 4
Stockholm 4
Tokyo 4
Vienna 4
Addis Ababa 3
Bogotá 3
Brasília 3
Chennai 3
Curitiba 3
Duque de Caxias 3
Falls Church 3
Istanbul 3
Jacksonville 3
Johannesburg 3
Las Vegas 3
Manchester 3
Martina Franca 3
Milwaukee 3
Moscow 3
Mumbai 3
Nairobi 3
Osasco 3
Philadelphia 3
Poplar 3
Salvador 3
San Diego 3
San Mateo 3
Shanghai 3
Tashkent 3
Toronto 3
Abidjan 2
Agadir 2
Amman 2
Asunción 2
Augusta 2
Baku 2
Bologna 2
Cali 2
Campinas 2
Caracas 2
Cinisello Balsamo 2
Da Nang 2
Denver 2
Des Plaines 2
Edmonton 2
Totale 2.592
Nome #
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 187
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 167
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center 165
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 163
Bone metastases in biliary cancers: A multicenter retrospective survey 163
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 149
Molecular classifications of gastric cancers: Novel insights and possible future applications 145
How Serious Games for Health Enhance Empowerment Related Patient Education: The Impact of Gender 144
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer 144
Metastatic gastric cancer in the last two decades: Goals achieved and future promises 142
Estimating survival probabilities of advanced gastric cancer patients in the second-line setting: The gastric life nomogram 141
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 141
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 140
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 140
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 137
HER-2 inhibition in gastric and colorectal cancers: Tangible achievements, novel acquisitions and future perspectives 135
Second-line chemotherapy in advanced biliary cancer: The present now will later be past 130
Immunotherapy for colorectal cancer: where are we heading? 128
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 125
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 119
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: A multicenter survey and pooled analysis with published data 113
Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158) 107
The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors 105
Immunotherapy for gastric cancers: emerging role and future perspectives 99
Il prototipo: Dimensioni e Nuclei tematici per contrastare l’Abbandono scolastico (DNA) 89
null 80
Social, constructivist and informal learning processes: Together on the edge for designing digital game-based learning environments 47
Totale 3.545
Categoria #
all - tutte 15.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022213 0 0 7 16 8 16 4 22 13 8 30 89
2022/2023483 52 82 44 45 44 51 10 51 70 5 25 4
2023/2024122 6 25 8 22 13 27 1 5 1 3 2 9
2024/2025495 6 13 36 11 12 76 26 45 16 30 95 129
2025/20261.098 212 57 48 58 169 81 128 21 117 94 22 91
2026/202789 21 32 36 0 0 0 0 0 0 0 0 0
Totale 3.545